Gener8tor's gBETA Medtech accelerator program, based in Minneapolis, announced the five members of its spring 2022 cohort Monday.
Over 140 companies applied for the free, seven-week program that works with startups focused on medical devices, healthcare-related software, biotech and diagnostics, Gener8tor said.
The program is capped at five companies so participants get the most out of their access to individualized coaching and access to a national network of mentors, partners and investors.
The cohort already got underway last month, and will culminate with a showcase day that highlights each company on June 21.
Madison, Wisconsin-based Gener8tor designed the program to allow startups to gain early customer traction and establish metrics helpful in joining equity-based accelerators or landing seed investments.
Gener8tor launched the accelerator in 2018 with St. Paul-based University Enterprise Labs, a shared lab space for biotechnology and life-sciences startups. The founding sponsor for the program was Boston Scientific and mentors for this cohort are pulled from the Mayo Clinic, the University of Minnesota and the Medical Alley Association.
Additional support comes from a cooperative agreement with the U.S. Department of Health and Human Services’ Division of Research, Innovation, and Ventures (DRIVe), established by the Biomedical Advanced Research and Development Authority (BARDA).
“We’re so fortunate to have such a diverse set of founders with expertise across the healthcare continuum,” said KC Caine, gBETA Director for the Medtech program. “Our founders are bringing high-impact innovations to the sector, and we’re excited to see how their companies grow.”
The five companies are:
Mother of Fact: A Langdon, N.H.-based mobile app supporting mothers as they feed their babies. This evidenced-based platform provides access to nutrition tracking, preventative monitoring, and daily coaching from licensed dietitians.
OmniVis: San Francisco-based company that developed a detection device to support international aid organizations and practicing physicians in diagnosing infectious diseases. OmniVis’ ultrasensitive handheld device provides a low cost solution to labor intensive lab testing, bringing accurate results directly to the point of care in under 30 minutes.
Q-rounds: Is a Minneapolis-based startup that provides an in-hospital digital health solution that sends real-time updates for patients, their families, and the care team on when to expect their doctor to arrive for inpatient rounds.
SingleTimeMicroneedles: Is a Farmington, Connecticut-based company that created a painless, removable, transdermal microneedle patch that can deliver vaccines in the comfort of a person’s home. STM’s vaccine delivery technology is the only platform engineered to deliver single or multiple dose vaccines in one application without needles or other equipment.
Tiumed: Is a Minneapolis-based surgical platform that targets benign prostatic hyperplasia (BPH) surgery, an enlarged prostate treatment that one in four men will require in their lifetime. Tiumed’s patented design doubles the tissue removal rate and increases surgeon control, improving procedure times, procedure completeness and number of procedures performed.
